On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

Hepatocellular carcinoma (HCC) is one of the most fatal malignancies. Epigenetic mechanisms have revealed that noncoding RNAs ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

However, the speed of vaccine production is limited because the mRNA used in it is partly chemically synthesized and partly ...

An mRNA vaccine, a cousin to the COVID vaccines that blunted the pandemic, has entered human trials as a treatment for lung ...

Researchers are exploring a new mRNA delivery technique to treat genetic conditions in the fetal brain, potentially ...

Everest Medicines’ Nefecon achieved 167 million yuan in sales in just over a month after its launch, showing its future big ...

A new study shows that a biomedical tool can successfully deliver genetic material to edit faulty genes in developing fetal brain cells. The technology, tested in mice, might have the potential to ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

A new vaccine provides hope for treating and even preventing the highly contagious and difficult-to-treat Clostridioides ...

Immunotherapy and precision medicine show promise in better fighting cancer. What else does the research tell us?